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Abstract: In mammals subverted as hosts by protozoan
parasites, the latter and/or the agonists they release are
detected and processed by sensors displayed by many
distinct immune cell lineages, in a tissue(s)-dependent
context. Focusing on the T lymphocyte lineage, we review
our present understanding on its transient or durable
functional impairment over the course of the develop-
mental program of the intracellular parasites Leishmania
spp., Plasmodium spp., Toxoplasma gondii, and Trypano-
soma cruzi in their mammalian hosts. Strategies employed
by protozoa to down-regulate T lymphocyte function may
act at the initial moment of naı¨ve T cell priming, rendering
T cells anergic or unresponsive throughout infection, or
later, exhausting T cells due to antigen persistence.
Furthermore, by exploiting host feedback mechanisms
aimed at maintaining immune homeostasis, parasites can
enhance T cell apoptosis. We will discuss how infections
with prominent intracellular protozoan parasites lead to a
general down-regulation of T cell function through T cell
anergy and exhaustion, accompanied by apoptosis, and
ultimately allowing pathogen persistence.
Introduction
Infections caused by the intracellular protozoa Leishmania spp.,
Trypanosoma cruzi, Plasmodium spp., and Toxoplasma gondii are
associated with high morbidity and a heavy economic toll. These
unicellular eukaryotes display complex life cycles whose successful
completion relies on shuttling between different hosts. Particular
selective pressures during host–pathogen coevolution shaped the
developmental program of each parasite, giving rise to distinct
clinical conditions (Box 1).
Protective immunity against parasitic infection is critically
dependent on the development of a multifunctional T cell
response that directly kills infected cells or induces phagocyte
activation to destroy intracellular parasites [1–3]. As blood or
tissue pathogens, their transmissibility to the insect vector or
definitive host is low, and thus these pathogens devised strategies
to dampen the T cell response and increase the time available for
parasite transmission [4].
After breaching epithelial barriers, intracellular protozoa
rapidly deploy strategies to resist innate mechanisms employed
by infection site–recruited immune cells, such as macrophages or
dendritic cells (DCs) [5,6]. These cells are also responsible for the
transition between innate immunity and the onset of the adaptive
response. As such, inhibiting the signals emanating from antigen-
presenting–cells (APCs) represents an ingenious strategy to delay
or hamper T cell responses [7], allowing rapid parasite replication
and dissemination during the acute stage of infection. Neverthe-
less, adaptive immunity eventually develops and is generally
associated with control of acute parasite infection [8–10]. Yet,
even in the presence of a robust T cell response, complete
pathogen eradication is rarely achieved, signalling the onset of
chronic infection, which may remain clinically silent throughout
the host’s life or give rise to complications several years after
primary infection. Chronic parasite persistence has a profound
impact on the effector capacity of T cells, inducing their gradual
loss of function in a phenomenon known as T cell exhaustion [11].
Spanning both acute and chronic stages of infection is the
programmed death of T cells, a homeostatic mechanism that
ensures the elimination of most specific T cells after clearance of a
foreign threat, yet allows the survival of a small number of memory
cells capable of long-term, antigen-independent survival [12].
However, by interfering with the apoptotic T cell process, parasites
may subvert the mechanisms of memory formation and reduce the
numbers of specific T cells available to fight the pathogen in the
long term [13].
Here, we review the current understanding of how intracellular
protozoan parasites subvert the host T cell immunity during the
full length of their developmental program within the mammalian
host, through mechanisms that favour the occurrence of T cell
anergy, exhaustion, and apoptosis.
Subverting the Signals Required for T Cell Activation
Results in Delayed or Anergic T Cell Responses
T cell anergy was initially described as a state of non-
responsiveness induced in vitro at the time of T cell stimulation,
via T cell receptor (TCR), in the absence of a costimulatory signal
[14]. Lack of costimulation results in defective nuclear recruitment
of the transcription factors required to initiate IL2 transcription
[7]. In this sense, anergy is usually induced in T cells that bind
their cognate peptide-MHC complexes displayed in the surface of
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not fully mature APCs, hence unable to provide adequate
costimulation [15]. In alternative, T cell anergy may be induced
after expression of immunomodulatory molecules by APCs,
including the ATP-catabolizing enzymes CD39 and CD73 or
the tryptophan-metabolizing enzyme indoleamine-2,3-dioxygen-
ase (IDO) [16]. These observations link the requirement of an
inflammatory and/or immunogenic environment to efficient T cell
activation (Table 1).
Even though the infection site and the anatomical location of
acute replication differ among the pathogens discussed here (Box
1), intracellular parasites share similar mechanisms to disturb the
functions of APCs and preclude effective T cell priming during the
acute phase of infection. For instance, in mice and humans, acute
toxoplasmosis is associated with a transient, anergic-like suppres-
sion of T cell function [17–19]. In vitro studies unveiled the ability
of T. gondii to down-modulate antigen presentation and costimu-
latory molecules in the infected APC [20–22]. Furthermore, a
strong association between reduced DC-derived signals and
decreased magnitude of the specific CD8 T cell response was
observed after infection of mice with tachyzoites of the lethal RH
strain, which is capable of remarkable dissemination through host
tissues within the first few days after infection [19].
In murine L. donovani infection, parasites colonize the liver and
quickly replicate, but hepatic infection self-resolves within one
month [10]. A recent study found that LIGHT (a TNF
superfamily ligand) signalling through the lymphotoxin-beta
receptor (LT-bR) was detrimental to the onset of the specific
CD4 T cell response, which may explain the rapid increase in
hepatic parasite numbers during the first week after inoculation.
An antibody therapy blocking LT-bR engagement by LIGHT
resulted in increased TNF production by hepatic CD4 T cells,
faster granuloma maturation and decreased hepatic parasite loads
[23]. In contrast with the liver, the spleen is the site of chronic
parasite persistence during murine visceral leishmaniasis. After L.
donovani infection in mice, the expansion and activation of splenic
CD8 T cells is delayed and lower in magnitude, when compared
with a prototypical acute infection [24]. A similar delay in the
onset of the splenic CD8 response was found during murine T.
cruzi infection [25].
Increased expression of immunomodulatory molecules in APCs
has also been noted in parasite infections [26–28]. Dendritic cells
expressing ATP-metabolizing enzymes or IDO emerge in the local
lymph nodes shortly after intradermal infection of mice with L.
amazonensis and L. major, respectively. These DCs were poor
inducers of T cell proliferation and, importantly, the T cell
response could be restored by blocking the adenosine receptor A2B
or IDO [26,27]. Interestingly, loss of IDO activity was recently
proposed as a biomarker for the restoration of the immune
response in treated leishmaniasis patients [29].
The liver stage of Plasmodium infection is very silent, both
clinically and immunologically, possibly due to a lack of
recognition of the intrahepatocytic merozoite by innate immunity
[30]. After deposition in the dermis, most sporozoites do not reach
the blood stream but are instead conveyed to the local lymph
nodes and digested inside DCs [31]. In mice inoculated with
irradiated sporozoites, CD8 T cells, primed by DCs in the skin-
draining lymph nodes, are able to migrate to the liver, recognize
infected hepatocytes, and provide protection [32]. Similarly, mice
given prophylactic chloroquine at the time of live sporozoite
inoculation are protected against subsequent challenge [33]. The
success of both immunization strategies seems to advent from the
development of a robust intrahepatic CD8 T effector/memory
response associated with high IFN-c production [34]. Thus,
efficient CD8 T cell priming can occur during Plasmodium
infections, and it is important to gain further knowledge of the
properties of the activated/matured APCs generated with these
immunization strategies, with the aim of optimizing vaccine
design.
Contrasting with hepatic infection, the blood stage of malaria is
noticeably immunogenic and, conversely, immune evasion mech-
anisms mediated by Plasmodium become apparent [30]. Splenic
DCs recognize and internalize Plasmodium-infected red blood cells
(pRBCs) but fail to stimulate T cells [35,36]. This ability correlates
with strain lethality [37] and is possibly caused by a systemic DC
activation that occurs very early after inoculation (1 to 4 days),
before the peak in parasitemia (days 4 to 7). As a consequence,
presentation of parasite antigens is short-lived, as activated DCs
Box 1. Developmental Programs of
Intracellular Parasitic Protozoa in the
Mammalian Host and Associated Clinical
Conditions
The kinetoplastids Leishmania spp. and T. cruzi and the
apicomplexans Plasmodium spp. all rely on insect vectors
for transmission to the mammalian host. After deposition
in the dermis through the bites of infected sand flies,
Leishmania parasites reside inside host phagocytes and,
depending on the infecting species, can either cause
localized cutaneous lesions (e.g., L. major) or visceral
leishmaniasis (L. donovani, L. infantum), a chronic disease
characterized by amastigote accumulation in visceral
compartments such as the spleen or the liver.
T. cruzi metacyclic trypomastigotes are transmitted by
the reduviid bug and cause an acute infection that lasts
some weeks and is characterized by systemic infection of
multiple host nucleated cells, within which the parasite
persists in a cytoplasmic location. Development of
adaptive immunity restricts parasite numbers and signals
the beginning of chronic infection, which may persist for
the life of the host. About two-thirds of the infected
patients will never be afflicted by clinical disease during
the chronic phase, while the remaining may develop
chagasic cardiomyopathy or digestive complications such
as megacolon or megaesophagus, usually 10 to 30 years
after the initial infection.
Anopheline mosquitoes transmit Plasmodium sporozoites
to the dermis of the host, initiating a developmental
program that starts with parasite migration to the liver.
The liver stage of infection is clinically silent but results in
remarkable replication of the merozoite form inside
hepatocytes. Merozoite egress from hepatocytes and
infection of erythrocytes initiates the blood stage of
infection and is responsible for the pathological sequelae
that are typically associated with malaria, which include
acidosis, anaemia, and cerebral malaria.
The apicomplexan T. gondii can infect humans through
ingestion of undercooked meat containing viable tissue
cysts or water contaminated with parasite oocysts. An
early acute phase, which usually passes unnoticed or
causes mild flu-like symptoms, is characterized by remark-
able parasite dissemination in the body due to the virtually
unlimited host cell range of the tachyzoite form. Strong
pressure posed by adaptive immunity induces parasite
differentiation to semidormant bradyzoites that form
tissue cysts in the brain and muscle, initiating chronic
infection that may last for the life of the individual.
Complications arise in the case of acquired immunodefi-
ciency and manifest as toxoplasmic encephalitis.
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become unable to phagocytose pRBCs, compromising T cell
activation [38].
Parasite-derived molecules may directly inhibit T cell activation.
Trans-sialidase, a glycoside hydrolase shed by T. cruzi, sialylates
the surface of activated CD8 T cells, reducing their affinity to
cognate peptide-MHC and decreasing their cytotoxicity [39].
Inhibition of trans-sialidase restored the CD8 T cell function and
increased mice survival [39]. In addition, AgC10, a T. cruzi GPI-
anchored mucin, binds to L-selectin in the surface of T cells and,
by interfering with the phosphorylation of TCR-associated signal
transducers, is capable of blocking IL2 transcription, rendering T
cells anergic during acute infection in mice [40].
Although anergy is viewed as a process regulating the initial
phase of the T cell response, the emergence of regulatory T cells
(Tregs) expressing immunomodulatory molecules, such as CTLA-
4, IDO, or ATP-metabolizing enzymes, during parasite infection
may contribute to sustaining T cell anergy during the chronic
phase [41–44].
Chronic Parasite Infection Leads to Exhaustion of Specific
T Cells
Immune exhaustion corresponds to a loss of effector function of
antigen-experienced T cells that occurs in a progressive manner,
starting with decreased proliferative ability, IL-2 production, and
cytotoxic function, followed by an incapacity to produce IFN-c
and TNF-a, and culminating with physical deletion at terminal
stages [11,45]. Exhausted T cells present high and sustained
expression of inhibitory molecules such as programmed death-1
(PD-1), T-cell immunoglobulin, and mucin domain-containing
protein-3 (TIM-3) and lymphocyte-activated gene-3 (LAG-3) [11]
(Table 1).
T cell exhaustion associated with chronic infection was initially
reported in viral models as specific CD8 T cells that failed to
produce cytokines [46]. Recent work conjectured a similar pattern
for chronic parasitic infections [47].
The occurrence of T cell exhaustion in viral models has been
classically associated with concomitant high and persistent antigen
levels [11]. In contrast, chronic parasite infections are character-
ized by lower pathogen burden, which is generally tissue-
restricted, suggesting alternative driving forces in the induction
of T cell exhaustion. For instance, acute T. gondii infection is
usually controlled by the development of adaptive immunity,
leading to parasite encystation and latency (Box 1). Nevertheless,
this does not preclude subsequent exhaustion of CD8 T cells.
Indeed, infection of C57Bl/6 mice with T. gondii cysts of the ME49
strain causes death in 7 weeks, associated with parasite reactivation
in the brain and concurrent with decreased numbers of brain-
infiltrating CD8 T cells and their reduced production of IFN-c
and granzyme B, an indication of cellular exhaustion [48].
Increased PD-1 expression accompanied T cell exhaustion, and a
treatment blocking the PD-1/PD-L1 pathway resulted in
reinvigorated T cell function and prevented animal demise
[48,49]. Recent data suggests that the CD40/CD40L axis plays
a crucial role in the rescue of exhausted CD8 T cells in the context
of a-PD-L1 therapy [1]. Importantly, reinvigoration of the CD8 T
cell response through CD40L-CD40 signalling occurred not only
in a CD8-intrinsic manner, but also by boosting CD4 helper cell
function through induction of increased production of IL-21 [1], a
cytokine previously shown to alleviate CD8 T cell exhaustion in
viral models [50,51].
In murine L. donovani infection, splenic CD8 T cells exhibit
exhaustion around 4–5 weeks after inoculation, with reduced
production of IFN-c, TNF, and granzyme B [24]. PD-1
expression in parasite-specific CD8 T cells and PD-L1 expression
in splenic DCs paralleled the decrease in T cell function and
blocking PD-1/PD-L1 interactions could reduce splenic parasite
burden [24]. In cutaneous leishmaniasis caused by L. mexicana,
expression of PD-1 in peripheral blood CD8 T cells correlates
with lesion severity being found in patients with diffuse but not
localized lesions [52].
In contrast, parasite-specific CD8 T cells do not undergo
functional exhaustion after mice infection with T. cruzi. Further-
more, after drug cure, CD8 T cells adopted a central memory
phenotype and protected against reinfection [53], a finding at odds
with the view that exhausted T cells are dependent on antigen
persistence and lost after antigen removal [11]. However, early
studies in human patients affected by chronic Chagas disease
evidenced a functional impairment of T cells that correlated with
severity of cardiac pathology [54–56]. The reason for this
dichotomy may lie in the much longer timeframe of human
infection (1–2 years in mice versus decades in humans),
presumably having a more severe impact on the functionality of
T cells.
In line with findings in chronic viral infection [57–59], during
parasitic disease, not only CD8 T cells are subjected to functional
exhaustion. Parasite-specific splenic CD4 T cells up-regulate PD-1
and LAG-3 and become exhausted by day 30 after mice infection
with P. yoelii–infected RBCs [60]. Simultaneous blockade of PD-1
and LAG-3 increased the numbers of multifunctional CD4 T cells
Table 1. T cell anergy versus T cell exhaustion.
Unresponsive
state
Differentiation
state affected Driving forces
General characteristics of the unresponsive
state
T cell anergy Naı¨ve/Effector Impaired antigen presentation Impaired activation and proliferation
Reduced costimulation Defective differentiation and effector function
Expression of immunomodulatory molecules (IDO, CD73, CD39) Apoptosis
Regulatory cytokines (IL-10, TGF-b)
T cell exhaustion Effector Antigen persistence, chronic activation Progressive impairment of effector function
Regulatory cytokines (IL-10, TGF-b) Expression of inhibitory receptors (PD-1, TIM-3,
LAG-3)
Suboptimal priming (while in the naı¨ve state) Decreased expression of common c chain
cytokine receptors
Apoptosis
doi:10.1371/journal.pntd.0002567.t001
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that produce IFN-c, TNF, and IL-2 and accelerated parasite
clearance [60]. In contrast, blockade of either PD-1 or LAG-3
alone had only modest effects on the recovery of functional CD4 T
cells or decrease in parasitemia, suggesting that inhibitory
receptors may play independent roles in the induction and/or
maintenance of the exhausted state and that combined therapies
might be more efficient in improving T cell fitness [61].
Importantly, caution has to be taken when classifying exhausted
CD4 T cells based solely on the expression of PD-1. A recently
described CD4 T cell subset, termed T follicular helper cells (Tfh),
which is essential for B cell–mediated immunity, is characterized
by the expression of PD-1 in association with the B cell follicle-
homing chemokine receptor, CXCR5. In this context, it is
interesting to note that a-PD-L1/a-LAG-3 therapy dramatically
increased P. yoelli–specific humoral responses and the numbers of
germinal centre B cells, presumably due to the accompanying
increase in the number of Tfh cells. These findings suggest that
therapeutic blockade of inhibitory receptors during chronic
parasite infection may have beneficial effects that extend beyond
the recovery of exhausted T cells. Finally, increased expression of
PD-1 and LAG-3 has been recapitulated in T cells from human
patients infected with P. falciparum [60,62].
It is worth mentioning, however, that despite their deleterious
role in sustaining T cell exhaustion during chronic infections,
inhibitory receptors protect host tissues during acute infection by
dampening potentially pathogenic T cell responses. During acute
T. cruzi infection in mice, ablating PD-1 signalling augments
cardiac inflammation due to increased infiltration of activated
CD4 and CD8 T cells [63]. Similarly, blocking the PD1/PD-L1
pathway during P. berghei ANKA infection promotes CD8 T cell
Figure 1. Mechanisms of T cell contraction after immune response resolution. T cell contraction after resolution of an immune response is
usually accomplished through a combination of mitochondria- and death receptor–dependent mechanisms. As a result of T cell expansion, survival
factors as IL-2 become scarce, and signalling through survival pathways, like the phosphoinositide 3-kinase (PI3-K)/Akt pathway, ceases, allowing
FoxO3-dependent Bim induction. Bim promotes mitochondrial outer membrane permeabilization (MOMP) by relieving the inhibitory effect that
antiapoptotic Bcl-2 and Bcl-xL exert on proapoptotic Bax and Bak. MOMP results in cytochrome-c release from the mitochondria, enabling activation
of a supramolecular complex, the apoptosome that activates caspase-3. By processing numerous cellular substrates, activated caspase-3 ensures
completion of the execution phase of apoptosis. T cell activation also induces Fas ligand expression in T cells, which, by engaging the death receptor
Fas, enables caspase-8 activation at the death-inducing signalling complex (DISC). Caspase-8 then activates caspase-3. If the levels of caspase-8–
activated caspase-3 are not sufficient to undertake apoptotic cell death, a mitochondrial amplification loop may occur through caspase-8–mediated
Bid cleavage. This generates tBid, a proapoptotic Bcl-2 family member that promotes MOMP by activating Bax and Bak.
doi:10.1371/journal.pntd.0002567.g001
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infiltration in the brain and augments the incidence of exper-
imental cerebral malaria (ECM) in otherwise ECM-resistant Balb/
c mice [61]. Thus, signalling through inhibitory receptors appears
to be a homeostatic mechanism that regulates effector cell function
at the peak of the response.
While T cell exhaustion is usually associated with chronic
infection, a recent study in the L. major mouse model suggests that
the fate of exhausted T cells may be influenced by the events at the
acute phase. Infection of otherwise resistant C57Bl/6 mice with
arginase-deficient (arg2/2) L. major causes chronic persistence of
cutaneous lesions associated with exhaustion of specific CD4 T
cells from the draining lymph nodes. The appearance of exhausted
CD4 T cells at the chronic phase appears to be a consequence of the
reduced primary CD4 response after infection with the
transgenic/attenuated parasite [64]. Possibly, the curtailed acute
response to arg2/2 parasites precludes effective parasite elimination,
which subsequently fosters the exhaustion of effector CD4 T
cells due to antigen persistence. Alternatively, it cannot be ruled
out that arg-deficient parasites are less fit in inducing APC
activation and maturation. This would preclude efficient T cell
activation and favour anergy. Given that the transcriptional profiles
of anergic and exhausted T cells partially overlap [65], it is plausible
that a naı¨ve T cell primed under suboptimal conditions is more
prone to undergo functional exhaustion at later stages of infection,
unveiling a possible relationship between the two states of T cell
responsiveness.
Figure 2. The uptake of apoptotic T lymphocytes by parasite-hosting phagocytes contributes to the remodelling of the parasite-
hosting tissue as a bona fide protective niche. Increased rates of T cell apoptosis occur during parasite infection, mediated either by death
receptor– or mitochondria-dependent mechanisms. Upon clearance, these apoptotic cells induce an alternative state of activation in phagocytes
associated with production of suppressive mediators as TGF-b and IL-10, as well as promoting parasite growth. Suppressive cytokines act on effector
T cells and, together with antigen persistence and inhibitory T cell receptors, induce exhaustion of these cells. Additionally, inhibition of antigen
presentation and costimulation, acting along with suppressive cytokines or enzymes (as IDO, which catabolizes tryptophan), may render naı¨ve T cells
anergic and unresponsive throughout infection. Eventually effector, anergic, or exhausted T cells undergo programmed cell death, fuelling the pool
of apoptotic corpses and aiding perpetuation of the suppressive state.
doi:10.1371/journal.pntd.0002567.g002
PLOS Neglected Tropical Diseases | www.plosntds.org 5 February 2014 | Volume 8 | Issue 2 | e2567
Immunoregulatory cytokines may also contribute to down-
regulate T cell function by inducing or maintaining the states of
exhaustion and anergy in protozoan infections [11,66]. IL-10
impairs monocyte and dendritic cell maturation, inducing their
deaths [67], which in turn may affect T cell effector function
[68]. In the context of parasite infections, IL-10 can play a
protective role by limiting tissue damage, as suggested by the
increased mortality observed in T. gondii and P. chabaudi
infections after IL-10 signalling neutralization [69,70], or
promote chronicity, as its neutralization during experimental
visceral leishmaniasis improved CD4 T cell responses and led to
disease resolution [71].
Finally, it is important to envision T cell exhaustion from a
host–parasite co-evolution perspective. In this sense, T cell
exhaustion may have evolved as a mechanism to avoid the
immunopathology that would otherwise result from chronic
pathogen persistence. Importantly, despite losing partial effector
function, exhausted T cells may still apply some degree of immune
pressure on the pathogen to attain the dynamic equilibrium that
characterizes chronic infection [11,72].
T Cell Apoptosis As a Pathological Component of
Protozoan Infections
Apoptosis of T lymphocytes during the contraction phase of an
immune response occurs through re-stimulation of activated T-cells
in a process termed activation-induced cell death (AICD), or results
from the absence of survival factors, known as activated T cell
autonomous death (ACAD) or death by neglect [12]. AICD is
usually accomplished through a death receptor-dependent mech-
anism. Upon activation, expression of death ligands, such as Fas
ligand (FasL, CD95L) or TNF increases in T cells, allowing caspase-
8 processing in the death-inducing signalling complex (DISC). In
contrast, ACAD is mediated by the relative balance of the Bcl-2
family members [12]. In particular, the increased expression of the
pro-apoptotic member Bim in T cells after cytokine deprival relieves
the inhibitory effect anti-apoptotic Bcl-2 and Bcl-xL exert on Bax
Table 2. Impact of targeted inhibition of suppressive or apoptotic T cell pathways in the outcome of parasitic infection.
Suppressive pathway
targeted Parasite Therapeutic approach Infection outcome Reference
T cell anergy Leishmania donovani Administration of an anti-LTbR
mAb (blocks LIGHT binding to
LTbR), started at the day of
infection
Increased TNF production by hepatic
CD4 T cells and promoted granuloma
maturation and parasite clearance
in the liver
[23]
Leishmania major Administration of an IDO
inhibitor, initiated 14 days
after infection
Increased CD4 T cell proliferation
and reduced footpad swelling and
parasite burden
[27]
Trypanosoma cruzi Treatment with inactive T. cruzi
trans-sialidase, started at the day
of infection
Treatment reverted the glycosylation
status of CD8 T cells, decreased acute
phase parasitemia and promoted
mice survival
[39]
T cell exhaustion Toxoplasma gondii Anti-PD-L1 therapy, starting at
5 weeks post-infection
Augmented IFN-c and granzyme
B production by CD8 T cells and
controlled Toxoplasma recrudescence
[48]
Leishmania donovani Anti-PD-L1 therapy, initiated
at day 15 after infection
Rescued L. donovani–specific CD8
T cells from exhaustion with increased
IFN-c production and reduced splenic
parasite burden
[24]
Plasmodium yoelii Anti-PD-L1 and anti-Lag3 therapy,
starting at day 14 post-infection
Reinvigorated splenic CD4 and CD8
T cells, improved anti-Plasmodium
humoral responses and decreased
parasitemia
[60]
T cell apoptosis Trypanosoma cruzi Administration of zVAD
(pan-caspase inhibitor), initiated
at day 7 after infection
Reduced T cell apoptosis, promoted
type 1 responses and reduced
parasitemia
[77]
Treatment with zLEHD (caspase-9
inhibitor), starting at 4 days post-
infection
Protected mesenteric lymph node
T cells from apoptosis and promoted
their cytokine production
[78]
Administration of an anti-FasL,
starting at 11 days after infection
Therapy protected T cells from AICD,
improved cytokine secretion and
decreased parasitemia
[90]
Therapy with zIETD (caspase-8
inhibitor), initiated 4 days
after infection
Treatment inhibited T cell expansion
and resulted in increased parasitemia
[95]
Plasmodium berghei Anti-IFN-c treatment, daily,
starting the first day after infection
Treatment prevented the deletion of
parasite-specific CD4 T cells during
acute phase of blood stage infection
[75]
Anti-IFN-c and anti-IL-12 treatment
initiated 1 day before infection
Treatment promoted differentiation of
long-lived memory CD4 T cells and
decreased parasitemia
[75]
doi:10.1371/journal.pntd.0002567.t002
PLOS Neglected Tropical Diseases | www.plosntds.org 6 February 2014 | Volume 8 | Issue 2 | e2567
and Bak. This results in mitochondrial outer membrane permea-
bilization (MOMP) and apoptosome formation [12] (Figure 1).
Several studies demonstrate that T cell apoptosis occurs during
natural or experimental infections with Leishmania spp. [73],
Toxoplasma gondii [74], Plasmodium spp. [75], and Trypanosoma cruzi
[76]. Furthermore, some studies showed evidence of augmented T
cell responses and increased mouse survival after caspase
inhibition during protozoan infection [77–79]. However, it is
frequently hard to discern from published work whether T cell
death is pathological or physiological [13,80]. This is particularly
notorious through the acute phase of infection, during which a
high turnover of T cells is expected and reflects the emergence and
shutdown of the primary response. Yet, even during the early
stages, regulation of apoptosis may impact the mechanisms of T
cell memory formation and compromise immunity during chronic
infection [81]. In this section, we examined the findings that
support a pathological component for T cell apoptosis during
protozoan infections, proceeding either through a death receptor
or mitochondria-dependent mechanism.
Involvement of death receptors. The first hint that death
receptor–mediated apoptosis of T cells exerts a negative impact in
the immune response during parasite disease came from studies
revealing augmented T cell responses in Fas, Faslg (FasL), or
TNF-deficient mice after parasite infection [82–86]. These studies,
however, also evidenced the importance of death receptor
signalling in the clearance of inflammatory infiltrates. Supporting
these results is the finding that serum levels of FasL are elevated in
patients chronically infected with P. falciparum [87], T. cruzi [88],
and L. donovani [89].
Further analysis defined the kinetics of Fas and FasL expression
and T lymphocyte apoptotic death during infection. Splenic CD4
and CD8 T cells start to express CD95 around the second to third
week after murine T. cruzi infection, which correlates with their
death by AICD [76,90]. Treatment with an anti-FasL, but not
anti-TNF or anti-TRAIL antibodies, could rescue both subsets
from apoptosis, improving T cell effector functions and protecting
mice from death [76,90].
Importantly, mice vaccinated with an adenoviral vector
expressing two T. cruzi–dominant epitopes presented improved
CD8 T cell functionality and decreased parasitemia after parasite
challenge, a phenotype attributed to the lack of CD95 expression
in parasite-specific CD8 T cells [76]. Recently, the RIG-I–like
receptor LGP2 was shown to repress CD95 expression in activated
CD8 T cells in a murine model of West Nile virus infection [91].
While a potential role for LGP2 in parasitic infections remains to
be addressed, this data has implications for vaccine design and
how it could fine-tune the immune response with the aim to
hamper death receptor signalling and improve T cell survival.
Also, the decreased levels of parasitemia in immunized and
infected animals may explain the lack of CD95 expression in CD8
T cells, due to lower immune activation [76].
Nevertheless, previous work has shown accelerated mice
mortality after T. cruzi infection in the absence of Fas signalling
[92], possibly due to excessive renal inflammation [93] and altered
cytokine patterns that favour the expansion of a non-protective
Th2 response [90]. Additionally, a recent study has revealed that a
polymorphism in the Fas promoter is associated with protection in
childhood malaria [94]. The protective Fas allele was associated
with higher expression of CD95 in PBMCs, which was interpreted
as facilitating T lymphocyte death and decreased immunopathol-
ogy. These examples further demonstrate the dual roles played by
death receptors, in particular Fas, during infection. On the one
hand, death receptor triggering may compromise T cell immunity,
but on the other hand, it prevents the pathogenic accumulation of
activated T cell clones and limits tissue pathology.
Finally, some studies aimed to address the magnitude and
functional properties of the T cell response after parasite infection
of Casp8 (caspase-8)-deficient mice or in the presence of caspase-8
inhibitors [77,95]. These, however, yielded conflicting results and
should be interpreted in view of the known role of caspase-8 in the
activation of NF-kB after TCR triggering [96].
Death by neglect. The limitation of survival factors upon
clonal expansion of activated T cells induces Bim expression in T
cells, triggering the mitochondrial pathway of apoptosis, in a
process known as death by neglect. By partnering with Fas-
dependent mechanisms, Bim-mediated apoptosis ensures clear-
ance of most effector T cell clones, yet allows the survival of a
minute number of self-sustaining memory T cells [97].
Perhaps the clearest example of how Bim-mediated T cell
apoptosis negatively affects the immune response during parasite
infection comes from the L. major mouse model. While long-term
immunity to L. major infection in resistant strains is thought to be
dependent on the persistence of a small number of parasites in
sheltered niches regulated by IL-10–producing effector or
regulatory T cells [98,99], sterile cure could be achieved after
Bim ablation [100]. These mice exhibited increased numbers of
parasite-specific CD4 T cells that produced IFN-c at the infection
site and draining lymph node and were protected from reinfection,
suggesting again that interfering with T cell death may boost
vaccine efficiency.
Recent evidence suggests that heightened expression of inflam-
matory mediators during the acute stages of infections exacerbates
the contraction phase of the immune response, compromising the
establishment of T cell memory [81]. During acute blood-stage
Plasmodium infection in mice, a significant proportion of parasite-
specific T cells undergo apoptotic demise. These could be saved by
blocking IFN-c signalling, but not TNF or Fas [75]. In a recent
study, a Plasmodium-encoded homologue of the macrophage
migration inhibitory factor (PMIF) was shown to potentiate the
Five Key Papers in the Field
1. Vasconcelos JR, Bruna-Romero O, Araujo AF, Dominguez
MR, Ersching J, et al. (2012) Pathogen-induced proapop-
totic phenotype and high CD95 (Fas) expression accom-
pany a suboptimal CD8+ T-cell response: reversal by
adenoviral vaccine. PLoS Pathog 8: e1002699.
doi:10.1371/journal.ppat.1002699
2. Joshi T, Rodriguez S, Perovic V, Cockburn IA, Stager S
(2009) B7-H1 blockade increases survival of dysfunctional
CD8(+) T cells and confers protection against Leishmania
donovani infections. PLoS Pathog 5: e1000431.
doi:10.1371/journal.ppat.1000431
3. Reckling S, Divanovic S, Karp CL, Wojciechowski S, Belkaid
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Sci U S A 108: 9196–9201.
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et al. (2012) Therapeutic blockade of PD-L1 and LAG-3
rapidly clears established blood-stage Plasmodium infec-
tion. Nat Immunol 13: 188–195.
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inflammatory response during acute blood-stage infection in mice.
As a result, the differentiation of splenic T cells is diverted towards
formation of short-lived terminal effector cells that die in a Bim-
dependent manner [101]. PMIF ablation or IL-12/IFN-c
neutralization instead promoted the differentiation of long-lived
memory T cells and ameliorated protection after reinfection [101].
Thus, a large proportion of T cell deaths during protozoan
infection might be the result of differentiation of terminal effector
T cells. In this sense, parasites exploit a host homeostatic pathway
to curtail the magnitude and duration of the T cell response.
Finally, it is important to recognize that this increased rate of
apoptotic T cell death is not without immunological consequences.
Phagocyte internalization of dying cells suppresses production of
inflammatory mediators but, instead, promotes expression of
TGF-b and IL-10 [102]. Due to their suppressive effects on APCs
functions, apoptotic cells may contribute to induce or maintain
anergy and exhaustion in T cells, helping to perpetuate a state of
down-regulated T cell function (Figure 2). Furthermore, internal-
ization of apoptotic cells may actually fuel parasite growth inside
macrophages, as observed for T. cruzi and L. major [103,104].
Concluding Remarks and Therapeutic Implications
The role of T cell immunity in controlling protozoan infection is
clearly established, as demonstrated by parasite reactivation in the
context of T cell immunodeficiency, such as co-infection with
HIV. Intracellular parasites engage in complex and long-lasting
interactions with the mammalian host during the full length of
their developmental programs. Such intricate co-existence pro-
vides several targets for therapeutics to intersect the infection and
ameliorate T cell function (Table 2).
Nevertheless, some caveats should be highlighted as we set the
stage to design future experiments in this area. First, experimental
routes of infection do not always reflect accurately the events of a
natural infection, particularly those early events associated with
parasite establishment. Moreover, in humans, protozoan infection
is often silent or less aggressive than mouse models, while also
having a longer timeframe. An additional caveat in studies with
human patients is the lack of analysis in deep tissues during the
chronic phase, as often only peripheral blood is available. All this
demands the introduction of alternative models that mimic the
natural routes and more closely resemble human infection. An
illustrative example comes from rats infected with T. gondii that
develop a long-lasting chronic infection similar to human infection
[105,106]. However, this model remains poorly documented in
the literature. Also, non-human primates (NHP) have proven to be
faithful models of several human infectious diseases, particularly in
AIDS research [107,108]. Unfortunately, the use of NHP models
in parasitic infections has been limited to pre-clinical drug or
vaccine evaluation or clinical description of the infection [109–
111], though recent studies have started to employ these models
for more in-depth immunological descriptions [112,113], (VR,
ACS, ML, AO, RS, and JE, submitted manuscript).
The mechanisms of impaired T cell function that we reviewed
here should be considered as complementary in effecting the
immune escape responsible for parasite persistence and disease. In
this context, the design of novel immunotherapies, such as
therapeutic vaccines, may gain advantage in incorporating
strategies that converge to restore immune competence.
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